| Giralt, Sergio |
| Active, not recruiting | 2 | 40 | US | Lenalidomide and bb2121, ide-cel, revlimid | Marcelo Pasquini, MD, National Heart, Lung, and Blood Institute (NHLBI), Blood and Marrow Transplant Clinical Trials Network, National Cancer Institute (NCI), National Marrow Donor Program, Celgene a wholly owned subsidiary of BMS | Multiple Myeloma | 01/25 | 04/25 | | |
NCT02570542: Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL) |
|
|
| Active, not recruiting | 2 | 59 | US | leukapheresis, Plerixafor, carmustine, etoposide, cytarabine, melphalan, BEAM chemotherapy, Autologous Stem Cell Transplantation | Memorial Sloan Kettering Cancer Center, Columbia University, NorthShore University HealthSystem, University of Rochester, Medical College of Wisconsin, University of Nebraska, Sanofi, University Hospitals Seidman Cancer Center | Diffuse Large B-cell Lymphoma (DLBCL), Relapsed Diffuse Large B-cell Lymphoma (DLBCL), Refractory Diffuse Large B-cell Lymphoma (DLBCL) | 10/25 | 10/25 | | |
NCT01745588: Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma |
|
|
| Active, not recruiting | 2 | 23 | US | Pomalidomide, stem cell, Dexamethasone, Clarithromycin | Memorial Sloan Kettering Cancer Center, Celgene Corporation, Weill Medical College of Cornell University, North Shore University Hospital, Rutgers Cancer Institute of New Jersey, State University of New York - Upstate Medical University | Multiple Myeloma | 12/25 | 12/25 | | |
NCT01758328: Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma |
|
|
| Active, not recruiting | 1 | 29 | US | busulfan, melphalan, fludarabine, anti-thymocyte globulin (ATG), a T cell depleted stem cell transplant | Memorial Sloan Kettering Cancer Center | Multiple Myeloma | 12/25 | 12/25 | | |
NCT03276481: Prospective Evaluation of Taste Function In Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation |
|
|
| Completed | N/A | 47 | US | Oral microbiota assessment, Comprehensive chemical gustometry, Measurement of salivary flow, Surveys assessing taste disturbances | Memorial Sloan Kettering Cancer Center | Multiple Myeloma | 07/23 | 07/23 | | |
NCT02677064: Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia |
|
|
| Recruiting | N/A | 1365 | US | assessments | Memorial Sloan Kettering Cancer Center | Acute Leukemia, Newly Diagnosed, Relapsed | 02/25 | 02/25 | | |
NCT02671448: Pilot Trial of Homebound Stem Cell Transplantation |
|
|
| Recruiting | N/A | 91 | US | Home monitoring teleconsult visits, Patient Reported Outcomes (PRO), Caregiver Reported Outcomes instruments | Memorial Sloan Kettering Cancer Center | Plasma Cell Dyscrasia | 01/27 | 01/27 | | |
| Recruiting | N/A | 200 | US | Circadian Effective Lighting, Circadian Ineffective Lightning (CIL) | Icahn School of Medicine at Mount Sinai | Multiple Myeloma | 06/27 | 06/27 | | |
